The Challenge: Ineffective Medical Representative Engagement with Psychiatrists
Pharmaceutical companies struggle to effectively engage psychiatrists, hindering advancements in mental health treatment and patient care.
The Loss: Impact on Patient Care and Treatment Innovation
Suboptimal MR activities lead to delayed adoption of new psychiatric treatments, resulting in prolonged patient suffering, higher healthcare costs, and missed opportunities for early intervention.
Data shows a direct link between effective engagement strategies and improved patient outcomes in psychiatry, emphasizing the critical need for targeted approaches to enhance physician education and patient care.
The Solution: Innovating MR Engagement for Psychiatrists
Pixika AI introduces a state-of-the-art mobile app designed to enhance MR engagement with psychiatrists. Our platform utilizes personalized digital strategies, including web-to-web and web-to-print solutions, to deliver targeted promotional inputs and educational resources.
We empower pharmaceutical companies to optimize their interactions with psychiatrists, accelerating the adoption of new treatments and improving patient outcomes in mental health.
Establishing Credibility
As pharmaceutical business growth experts, Pixika AI collaborates with over 70 top global healthcare companies, impacting approximately 500,000 doctors annually through digital and print initiatives. Our solutions have significantly contributed to achieving cumulative revenues of 9700 crores and maintaining an average rating of 4.1 stars from 75% repeat customers.